METTL3 and acute myeloid leukemia: The METTL3 m6A “writer” was also identified as a critical regulator of a chromatin-based pathway that maintained cells in a leukemic state, where the inhibition of METTL3 removed the myeloid differentiation block in human and mouse AML cells [986].